121 related articles for article (PubMed ID: 26851089)
1. New look inside human breast ducts with Raman imaging. Raman candidates as diagnostic markers for breast cancer prognosis: Mammaglobin, palmitic acid and sphingomyelin.
Abramczyk H; Brozek-Pluska B
Anal Chim Acta; 2016 Feb; 909():91-100. PubMed ID: 26851089
[TBL] [Abstract][Full Text] [Related]
2. Corrigendum to "New look inside human breast ducts with Raman imaging. Raman candidates as diagnostic markers for breast cancer prognosis: Mammaglobin, palmitic acid and sphingomyelin" [ACA 909, (2016) 91-100].
Abramczyk H; Brozek-Pluska B
Anal Chim Acta; 2018 Aug; 1019():142. PubMed ID: 29625681
[No Abstract] [Full Text] [Related]
3. Double face of cytochrome c in cancers by Raman imaging.
Abramczyk H; Brozek-Pluska B; Kopeć M
Sci Rep; 2022 Feb; 12(1):2120. PubMed ID: 35136078
[TBL] [Abstract][Full Text] [Related]
4. The utility of villin and mammaglobin in the differential diagnosis between intrahepatic cholangiocarcinoma and breast cancer.
Yang Z
Appl Immunohistochem Mol Morphol; 2015 Jan; 23(1):19-25. PubMed ID: 25153498
[TBL] [Abstract][Full Text] [Related]
5. SERS studies on normal epithelial and cancer cells derived from clinical breast cancer specimens.
Shen L; Du Y; Wei N; Li Q; Li S; Sun T; Xu S; Wang H; Man X; Han B
Spectrochim Acta A Mol Biomol Spectrosc; 2020 Aug; 237():118364. PubMed ID: 32361317
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical Markers for Distinguishing Metastatic Breast Carcinoma from Other Common Malignancies: Update and Revisit.
Ding Q; Huo L; Peng Y; Yoon EC; Li Z; Sahin AA
Semin Diagn Pathol; 2022 Sep; 39(5):313-321. PubMed ID: 35461734
[TBL] [Abstract][Full Text] [Related]
7. Human mammaglobin: A specific marker for breast cancer prognosis.
Li C; Zhang T
J BUON; 2016; 21(1):35-41. PubMed ID: 27061528
[TBL] [Abstract][Full Text] [Related]
8. Peripheral blood mammaglobin gene expression for diagnosis and prediction of metastasis in breast cancer patients.
Radwan WM; Moussa HS; Essa ES; Kandil SH; Kamel AM
Asia Pac J Clin Oncol; 2013 Mar; 9(1):66-70. PubMed ID: 22897908
[TBL] [Abstract][Full Text] [Related]
9. Electrochemical genosensor for detection of human mammaglobin in polymerase chain reaction amplification products of breast cancer patients.
Xu X; Weng X; Liu A; Lin Q; Wang C; Chen W; Lin X
Anal Bioanal Chem; 2013 Apr; 405(10):3097-103. PubMed ID: 23341004
[TBL] [Abstract][Full Text] [Related]
10. The Novel Marker GATA3 is Significantly More Sensitive Than Traditional Markers Mammaglobin and GCDFP15 for Identifying Breast Cancer in Surgical and Cytology Specimens of Metastatic and Matched Primary Tumors.
Sangoi AR; Shrestha B; Yang G; Mego O; Beck AH
Appl Immunohistochem Mol Morphol; 2016 Apr; 24(4):229-37. PubMed ID: 25906123
[TBL] [Abstract][Full Text] [Related]
11. The lipid-reactive oxygen species phenotype of breast cancer. Raman spectroscopy and mapping, PCA and PLSDA for invasive ductal carcinoma and invasive lobular carcinoma. Molecular tumorigenic mechanisms beyond Warburg effect.
Surmacki J; Brozek-Pluska B; Kordek R; Abramczyk H
Analyst; 2015 Apr; 140(7):2121-33. PubMed ID: 25615557
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic changes in cancer by Raman imaging, fluorescence imaging, AFM and scanning near-field optical microscopy (SNOM). Acetylation in normal and human cancer breast cells MCF10A, MCF7 and MDA-MB-231.
Abramczyk H; Surmacki J; Kopeć M; Olejnik AK; Kaufman-Szymczyk A; Fabianowska-Majewska K
Analyst; 2016 Oct; 141(19):5646-58. PubMed ID: 27460599
[TBL] [Abstract][Full Text] [Related]
13. Plasma mammaglobin messenger RNA in breast cancer patients as an addition to serum tumor.
El-Attar NI; Gaefar HA
Egypt J Immunol; 2007; 14(2):111-21. PubMed ID: 20306663
[TBL] [Abstract][Full Text] [Related]
14. Mammaglobin peptide as a novel biomarker for breast cancer detection.
Galvis-Jiménez JM; Curtidor H; Patarroyo MA; Monterrey P; Ramírez-Clavijo SR
Cancer Biol Ther; 2013 Apr; 14(4):327-32. PubMed ID: 23358476
[TBL] [Abstract][Full Text] [Related]
15. Disseminated tumor cells in bone marrow assessed by TWIST1, cytokeratin 19, and mammaglobin A mRNA predict clinical outcome in operable breast cancer patients.
Tjensvoll K; Oltedal S; Farmen RK; Shammas FV; Heikkilä R; Kvaløy JT; Gilje B; Smaaland R; Nordgård O
Clin Breast Cancer; 2010 Oct; 10(5):378-84. PubMed ID: 20920982
[TBL] [Abstract][Full Text] [Related]
16. Raman spectroscopy of normal and diseased human breast tissues.
Frank CJ; McCreery RL; Redd DC
Anal Chem; 1995 Mar; 67(5):777-83. PubMed ID: 7762814
[TBL] [Abstract][Full Text] [Related]
17. Advances in Raman imaging combined with AFM and fluorescence microscopy are beneficial for oncology and cancer research.
Abramczyk H; Imiela A; Brozek-Pluska B; Kopec M
Nanomedicine (Lond); 2019 Jul; 14(14):1873-1888. PubMed ID: 31305216
[No Abstract] [Full Text] [Related]
18. Co-expression and prognostic value of gross cystic disease fluid protein 15 and mammaglobin in primary breast cancer.
Fritzsche FR; Thomas A; Winzer KJ; Beyer B; Dankof A; Bellach J; Dahl E; Dietel M; Kristiansen G
Histol Histopathol; 2007 Nov; 22(11):1221-30. PubMed ID: 17647195
[TBL] [Abstract][Full Text] [Related]
19. Biochemical analysis of human breast tissues using Fourier-transform Raman spectroscopy.
Bitar RA; Martinho Hda S; Tierra-Criollo CJ; Zambelli Ramalho LN; Netto MM; Martin AA
J Biomed Opt; 2006; 11(5):054001. PubMed ID: 17092150
[TBL] [Abstract][Full Text] [Related]
20. [Raman imaging based on morphological model for human breast cancer tissues].
Yu G; Lü AJ; Wang B; Zhang CZ
Guang Pu Xue Yu Guang Pu Fen Xi; 2010 Aug; 30(8):2167-70. PubMed ID: 20939331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
